Lunasin, a peptide found naturally in soybeans, shows cancer-preventive and cancer-fighting properties in lab studies by modifying gene expression and targeting cancer stem cells.
Dual anticancer mechanismLunasin uniquely targets cancer through both epigenetic modulation (histone acetylation) and integrin signaling disruption in cancer stem cells
What the researchers found
Lunasin, a peptide naturally found in soybeans, has demonstrated both cancer-preventive (chemopreventive) and cancer-fighting (therapeutic) properties against multiple cancer types in preclinical studies. What makes lunasin unique is that it contains multiple functional domains that work through two distinct mechanisms: modifying gene expression by affecting histone acetylation (epigenetic regulation) and disrupting integrin signaling in cancer cells.
Recent studies highlighted in this review show that lunasin's effects on integrin signaling in cancer stem cells are particularly noteworthy — it reduces the expression of stemness factors, which are the genes that allow cancer stem cells to maintain their aggressive, self-renewing properties. This leads to a reduction in metastatic potential, meaning the cancer becomes less likely to spread. The peptide's dual mechanism of action through both epigenetic and cell signaling pathways sets it apart from most single-target anticancer agents.
Why it matters
The link between soy consumption and reduced cancer risk has been observed in population studies for decades, but the specific compounds responsible have been debated. Lunasin represents a concrete molecular explanation — a bioactive peptide that can both prevent cancer initiation and fight existing tumors. Its ability to target cancer stem cells is especially significant because these cells drive metastasis and treatment resistance.
The numbers in context
Lunasin = soy-derived peptide · Active against multiple cancer types · Dual mechanism: histone acetylation + integrin signaling · Reduces cancer stemness factors · Reduces metastatic potential
How the study worked
Narrative review published in Current Opinion in Pharmacology, highlighting recent preclinical studies on lunasin's anticancer mechanisms, with emphasis on its effects on histone acetylation, integrin signaling, and cancer stem cell biology.
Who was studied
Not applicable (review of preclinical cancer research)
What this study cannot tell us
All anticancer evidence for lunasin is preclinical — no human clinical trials for cancer treatment have been completed. The jump from soy-derived peptide activity in cell cultures and animal models to human therapeutic application is substantial. Bioavailability of dietary lunasin (from eating soy) versus purified lunasin delivery may differ significantly. Published in 2018, so some cited studies may have been superseded.
How to read the evidence
Published in Current Opinion in Pharmacology, a respected review journal. However, all anticancer evidence for lunasin remains preclinical — based on cell culture and animal studies. No human clinical trial data for cancer applications is available.
When this study was published
Published in 2018. Provides a good overview of the state of lunasin research at that time. Some findings may have been updated by more recent studies.
The bigger picture
Lunasin sits at the intersection of food-derived bioactive peptides and cancer pharmacology. It represents a growing trend of discovering drug-like molecules in dietary proteins — peptides that survive digestion and have measurable biological effects. If lunasin can be developed into a clinical therapy, it would validate the broader concept that food-derived peptides can be engineered into medicines, opening the door for similar discoveries from other protein sources.
Questions still open
- Can sufficient lunasin be obtained from dietary soy consumption to achieve the anticancer effects seen in preclinical studies?
- Will lunasin's anti-cancer stem cell activity translate to reduced metastasis in human clinical trials?
- Could lunasin be combined with conventional chemotherapy to enhance outcomes while reducing side effects?
Common questions
What is lunasin and where does it come from?
Can eating soy give you enough lunasin to fight cancer?
Read the original research
Development of the plant-derived peptide lunasin as an anticancer agent.
Current opinion in pharmacology, 41, 27-33
Citation
Vuyyuri, Saleha B; Shidal, Chris; Davis, Keith R. (2018). Development of the plant-derived peptide lunasin as an anticancer agent.. Current opinion in pharmacology, 41, 27-33. https://doi.org/10.1016/j.coph.2018.04.006